Laurus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LAURUS, and what generic and branded alternatives to LAURUS drugs are available?
LAURUS has fourteen approved drugs.
There are seven tentative approvals on LAURUS drugs.
Drugs and US Patents for Laurus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laurus | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 212579-003 | Apr 30, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | GABAPENTIN | gabapentin | CAPSULE;ORAL | 217546-002 | May 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; emtricitabine; tenofovir disoproxil fumarate | TABLET;ORAL | 213541-001 | Dec 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | LOPINAVIR AND RITONAVIR | lopinavir; ritonavir | TABLET;ORAL | 213857-002 | Mar 21, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.